Chemotherapy with 5-fluorouracil

PreclinicalSmall molecule

Chemotherapy with 5-fluorouracil is one of 28 small molecule programs targeting Chemoradiotherapy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

ChemoradiotherapyRecruiting

ChemoradiotherapyPreclinical

Recruiting

Competition

Competitive Landscape

31 competitors in Chemoradiotherapy

#DrugCompanyPhaseTrials

Eloxatin

Teva

Phase 3

4 2

Xeloda

EEngelhard Arzneimittel GmbH & Co.KG

Phase 3

10 3

Taxol

Teva

Phase 3

1 4

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

8 5

Paraplatin

AAvyxa

Phase 3

2 6

Tyvyt

Innovent Biologics (Suzhou) Co. Ltd.

Phase 3

2 7

Tuoyi

CCoherus Oncology, Inc.

Phase 3

2 8

Theraplaza

BBiotech Pharmaceutical Co., Ltd.

Phase 3

1 9

Immunotherapy

Bristol-Myers Squibb

Phase 3

2 10

Platinum Based Chemotherapy

Roche

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2037

PreclinicalRecruiting

Rectal Cancer

NCT06831981

Clinical

Trials by Indication[1]

Rectal Cancer1 trial

Radiochemotherapy With Concomitant Deep Regional Hyperthermia in Locally Advanced Rectal Cancer. A Prospective, Randomized Phase III Trial.

Recruiting·UUniversity Hospital Tuebingen·Preclinical·NCT06831981·264 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Chemotherapy with 5-fluorouracil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Chemotherapy with 5-fluorouracil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Chemotherapy with 5-fluorouracil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital Tuebingen company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital Tuebingen

Chemotherapy with 5-fluorouracil

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2037

Trials by Indication[1]

Rectal Cancer1 trial

References

Drug Info

Quick Facts

Related News